Table 3.
At the moment of discharge | After 1 month | ||||||||
---|---|---|---|---|---|---|---|---|---|
n = 1072 | M, n = 668 | F, n = 404 | P* | n | M, n = 668 | F, n = 404 | P* | P** | |
Subjective | |||||||||
Headache | 12 (1.1%) | 6 (0.9%) | 6 (1.5%) | 0.38 | 101 (9.4%) | 56 (8.4%) | 45 (11.1%) | 0.08 | <0.05 |
Vertigo | 7 (0.7%) | 4 (0.6%) | 3 (0.7%) | 0.79 | 29 (2.7%) | 22 (3.3%) | 7 (1.7%) | 0.09 | <0.05 |
Sleep disorders | 22 (2.1%) | 14 (2.1%) | 8 (2%) | 0.86 | 10 (0.9%) | 8 (1.2%) | 2 (0.5%) | 0.23 | <0.05 |
Fatigue | 0 (0%) | 0 (0%) | 0(0%) | 47 (4.4%) | 34 (5.1%) | 13 (3.2%) | 0.15 | <0.05 | |
n – total | 39 (3.6%) | 24 (3.6%) | 15 (3.7%) | 0.99 | 118 (11%) | 70 (10.5%) | 48 (11.9%) | 0.5 | <0.05 |
Cognitive | |||||||||
Irritability | 0 | 0 | 0 | 23 (2.1%) | 15 (2.2%) | 8 (2%) | 0.77 | <0.05 | |
Concentration disorders | 42 (3.9%) | 26 (3.9%) | 16 (4%) | 1 | 18 (1.7%) | 14 (2.1%) | 4 (1%) | 0.15 | <0.05 |
Memory impairment | 7 (0.7%) | 2 (0.3%) | 5 (1.2%) | 0.07 | 30 (2.8%) | 22 (3.3%) | 8 (2%) | 0.17 | <0.05 |
n – total | 49 (4.6%) | 28 (4.2%) | 21(5.2%) | 0.48 | 48(4.5%) | 36(5.4%) | 12(3%) | <0.03 | 0.91 |
Psychiatric | |||||||||
Depression | 10 (0.9%) | 5 (0.7%) | 5 (1.2%) | 0.43 | 11 (1%) | 6 (0.9%) | 5 (1.2%) | 0.61 | 0.82 |
Anxiety | 11 (1%) | 5 (0.7%) | 6 (1.5%) | 0.25 | 5 (0.5%) | 3 (0.4%) | 2 (0.5%) | 0.93 | 0.13 |
Psychotic symptoms | 13 (1.2%) | 7 (1%) | 6 (1.5%) | 0.54 | 1 (0.1%) | 0 (0%) | 1 (0.2%) | <0.05 | |
Psychoorganic symptoms | 2 (0.2%) | 2 (0.3%) | 0 (0%) | 2 (0.2%) | 2 (0.3%) | 0 (0%) | 1 | ||
n – total | 31 (2.9%) | 17(2.5%) | 14(3.5%) | 0.41 | 16(1.5%) | 10(0.9%) | 6(1.5%) | 0.93 | <0.05 |
Neurological | |||||||||
Upper limbs paresis | 34 (3.2%) | 21 (3.1%) | 13 (3.2%) | 0.99 | 22 (2.1%) | 14 (2.1%) | 8 (2%) | 0.88 | 0.1 |
Lower limbs paresis | 22 (2.1%) | 15 (2.2%) | 7 (1.7%) | 0.53 | 10 (0.9%) | 6 (0.9%) | 4 (1%) | 0.9 | <0.05 |
Sensation disorders | 14 (1.3%) | 7 (1%) | 7 (1.7%) | 0.34 | 6 (0.6%) | 3 (0.4%) | 3 (0.7%) | 0.54 | 0.07 |
Cranial nerves paresis | 23 (2.1%) | 11 (1.6%) | 12 (3%) | 0.14 | 13 (1.2%) | 5 (0.7%) | 8 (2%) | 0.07 | 0.1 |
Cerebellar syndrome | 64 (6%) | 41 (6.1%) | 23 (5.7%) | 0.68 | 13 (1.2%) | 9 (1.3%) | 4 (1%) | 0.58 | <0.05 |
n – total | 101 (9.4%) | 60 (9%) | 41 (10.1%) | 0.57 | 47 (4.4%) | 31 (4.6%) | 16 (4%) | 0.49 | <0.05 |
*Comparison between males and females.
**Comparison of the overall number of symptoms at the moment of discharge and during the follow-up.